chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swelling in her left arm. It was red/swollen down to elbow and hand; It was red, hot; body rash all over/rash on her hand; itchy; swollen down to elbow and hand; effected her movement of her hand; temperature abnormal; chills; hot swollen arm down to elbow; This is a spontaneous report from a contactable consumer (patient). An 80-year-old female patient received pneumococcal 13-valent conjugate vaccine (Diphtheria CRM197 Protein) (PREVNAR 13, Solution for injection in pre-filled syringe, lot number: PAA135492), via an unspecified route of administration, in arm left, on an unknown date in Oct2020, as a single dose for immunization and influenza a(h1n1) pdm09 vaccine (INFLUENZA) via an unspecified route of administration, on an unknown date in Oct2020, as a single dose for Immunization. Patient's medical history and concomitant medications were not reported. It was stated that she did have a pneumonia vaccine, Pfizer in October of last year and didn't have any breathing problems but she did have severe swelling in her left arm. It was red, hot, swollen down to elbow and hand and effected her movement of her hand. Stated that 30 days later, she had terrible body rash all over that was so itchy it was like poison ivy. Stated that she didn't know if that was related to the shot or something in it and she did have that last fall with the shot not breathing problems, but temperature abnormal, chills, red, hot swollen arm down to elbow and severe rash on her hand and all over her body 30 days later; all events were occurred to the patient on an unknown date in 2020. Confirmed that events occurred on left arm. She added, on the same day she also got the Influenza vaccine. No additional details provided. Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Upon receiving the flu shot, felt soreness in left arm near where it was administered. Was told this was normal and experienced this symptom before.  However, the pains worsened throughout the day, especially around 2:30.  By 4:00 was experiencing strong stomach pains and back pains. I felt like someone took me and hit me into a metal locker over and over again.  When parents returned from a walk at approximately 6:30, I was screaming and crying in pain which is very unusual for me since I have a relatively high pain tolerance.  My mom called a nurse, and my dad took my temperature seeing that I was holding a heating pad on my stomach and complaining that I was freezing.  Upon realizing my temperature soared to a 103, I was taken to the Emergency Room where I screamed in pain for another 3 hours.  My fever had apparently gone down so I just had to wait. At around 10 PM I was given morphine, Benadryl, antinausea medicine, and an IV.  After monitoring, I was realeased to go home at 1:40 AM on 10/24/2015. I took Tylenol as my temperature was 100.9 degrees when I went home, and I continued taking Tylenol for the next day or so.  I proceeded to sleep and watch TV for the next 2 1/2 days since I was so tired out from everything.
Patient was seen at Outreach for the COVID19 vaccine clinic. Patient lied about her age on registration form and was given the Moderna vaccine. When staff was able to register patient in system they discovered her birthdate was different.
Patient received Moderna Bivalent Booster dose given as vaccine #1 in Primary series rather than the Bivalent dose designated for Primary Series.
Client got up from a sitting position about 5 minutes after administration.  Stood with back against the vaccine fridge then eyes rolled back and he slumped to the ground.
PATIENT STATED HAVING PAIN ALL OVER THAT STARTED 3 DAYS AFTER RECEIING VACCINE
Pt recv vax on 11/9/98; 8 hr post vax pt exp stiff neck w/ LA & hand extended x several sec; pt to neurologist
A non-serious spontaneous report of bruising has been received from a registered nurse concerning an eight-year-old male, subsequent to FLUMIST. The patient's medical history includes epilepsy described as staring episodes-date of diagnosis unknown. Concomitant medications included divalproex (discontinued Mar-2009) and lamotrigine (16-Mar-2009-ongoing). His last vaccination was administered in 2006. The patient received his first dose of FLUMIST 04-Sep-2009. On 20-Sep-2009, the patient's mother reported to his primary care physician's office that her son had bruises on his legs from an unknown cause. On 23-Sep-2009, the patient's mother reported her son now had bruises under his arms. The patient presented to his primary care physician with multiple bruises and an unspecified amount of weight loss. His respiratory rate was 18 breaths per minute, heart rate was 88 beats per minute and body temperature was 98.5 degrees Fahrenheit. A registered nurse in the primary physician's office noted that physician reported the bruises appeared to be consistent with idiopathic thrombocytopenia purpura. The patient had no nose bleeds or buccal hemorrhages. Labs were drawn. No treatment was provided and the physician indicated the patient should follow-up as needed. On 24-Sep-2009, the lab results showed a platelet count "within normal limits" at 433,000. The final diagnosis was bruising. The bruises were caused by an specified trauma. On 28-Sep-2009, the bruising resolved. Additional information was received on 16-Oct-2009 and incorporated into the narrative: included final outcome and identified cause of bruising as unspecified trauma.
39 year old male just arrived. Sat five minutes started C/O dizziness, SOB, Chest Pressure 5 on scale of 1 to 10. BP 155/100, Resp 96. Then started to c/o nausea, HA, upset stomach. male went to restroom 911 called. Male still c/o of headache, nausea, and dizziness. 911 arrived at 10:42AM. EMT assessed male, 12 lead EKG completed results normal. Pulse 97, HR 75, BP 160/92. Male refused to go to ER. He did drink 32 oz of water stated he felt a little better. Advised to seek medical care. Left at 10:55am under his own power. Phone call this morning, patient Stated he was doing much better started working. Will make an appointment for medical doctor next week. Patient also stated when he returned home he did home remedies that helped him.
Shingles appeared on right abdomen and back about 48 hours after receiving the vaccines.
Onset of sweats, chills, rigors, aches in hips, knees and elbows as well as sternum starting approx. 11 hr post dose. (Medicated with naproxen approx. 5 hrs prior to onset of Sx). Re-medicated with acetaminophen at 2 AM. Continued sweats and chills until approx. 36 hrs post dose. Decreased appetite and energy for an additional 24 hrs. Some loss of work time. Mild erythema at injection site 48 hrs later (with expected ongoing muscular soreness at injection site). Similar (but less intense) response without anorexia and sternal ache after 1st dose in series which had resolved after 24 hrs.
Moderna Dose 1 3/25/21 (017B21A) Moderna Dose ? 3/30/21 (probably mistakenly recorded by human error) Moderna Dose 2 4/23/21 (006C21A) Presented to ED and transferred 9/30/21 COVID Positive 10/1/21  10/1/21:A 76-year-old male past medical history significant for diverticulosis status post bowel resection, essential hypertension, GERD, type 2 diabetes mellitus,  presented to Emergency Room after s/p fall and bloody bowl movement of 1 day.  Patient endorses that she was going to the bathroom when walker "went ahead "of her and fell to the ground.  She was unable to get up and laid on the ground for 2 hours until EMS arrival .  While laying on the ground  patient had the urge to defecate and  had bowel movement.  Per EMS and patient there was dark tarry stool mixed with blood.  Patient denied any abdominal pain nausea or vomiting. Patient denied any previous melena or hematemesis   Patient was diagnosed with COVID-19 infection on 09/29/2021 and got plasma infusion to days back.  Patient was also vaccinated with modern a COVID-19 vaccine in July 9 to August  .   Patient had colonoscopy in 2018 and per patient had removal of polyps.  Patient also had bowel resection surgery in 2011 for diverticulosis  In the emergency room  lab was significant for low sodium of 129, elevated blood glucose of 297 with BUN/creatinine ratio of 36. Hemoglobin was 11.9.  COVID-19 done on 09/27/2021 was positive.  CT abdomen and pelvis with IV contrast showed duodenitis, possibly related to peptic ulcer disease.  No perforation; cholelithiasis without evidence of acute cholecystitis.  Patient was started with Protonix drip by the referring physician   10/3/21: 76-year-old female with a history of HTN, T2 dm, GERD and the bowel resection for diverticulosis admitted for episode of probable syncope and melena stools.  She has a chronic headache for which she takes NSAIDs regularly. At the emergency room the vital signs were normal.  The hemoglobin was 11.9 grams/dL.  Routine COVID 19 screen came back positive but patient has no respiratory symptoms and she is fully vaccinated against COVID 19. She was diagnosed with likely upper GI bleed was admitted to hospital.  Later that night she had upper GI endoscopy and it revealed a medium-sized hiatal hernia, diffuse gastritis, clean based pre-pyloric ulcer, multiple large distal duodenal bulb ulcer.  Patient required placement of a hemoclip for a visible ulcer in the duodenal bulb with successful hemostasis.  Back to the medical ward she has been doing fine and hemoglobin fairly stable.  She has been on pantoprazole infusion since admission.  On re-evaluation this morning she feels fine was able to eat solid meal without any complaint.  The repeat hemoglobin this morning is 9.5 grams/dL which is stable.  She will be discharged home and will continue with oral pantoprazole 40 mg b.i.d. until re-evaluated by the gastroenterologist. Gastric/Duodenal biopsy for Helicobacter pylori is pending and hopefully will be available when she follows up with the GI specialist.
Patient came into clinic 05/24/2021 with fever, shivers, body aches and loss of appetite. Patient was tested for Covid ( rapid testing), once test results showed negative, patient was informed to go to ER in regards to side effects.
Expired vaccine administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Aug-2021, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment details were reported. It was reported that vaccine that shows on Moderna website as expired August 14, 2021 but also expired on October 14, 2022.
Hives began 9/15/11 in AM - treated with BENADRYL.
5-6 hours after vaccine dose, began to have extremely high fever (102), searing pain across forehead (like forehead was on fire), usual symptoms of sore arm, etc. The 102 fever lasted about 4 nights. Still had 99-101 for 3 more days. By 9/1/21 no longer had a fever, but still had the burning sensation in the forehead and migraine, which did not dissipate until 9/8/21.  Took tylenol, which would temporarily help the fever/burning, but headache would remain.  Not enough to fully resolve pain. Doctor wanted to prescribe steroid pack, but did not end up taking the steroids because I am currently in fertility treatment.
Heightened sense of smell; This spontaneous case from the was retrieved on 29-Aug-2022 from Vaccine Adverse Event Reporting System (VAERS) (reference number: 2098470-1), reported by other healthcare professional and concerned a 53-year-old, male patient.  The patient's concurrent conditions included type two diabetes and atrial fibrillation. The patient's concomitant medications were not reported.  On 06-Oct-2021, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine inact split 4v; route of administration: intramuscular (IM), anatomical location: left arm (LA), dose: reported as '1', and indication: not reported). The batch number reported was P100352313.   On the same date, the patient was vaccinated with non-company, co-suspect Pfizer BioNTech COVID-19 vaccine (tozinameran; route of administration: IM, anatomical location: right arm (RA), dose: reported as '3', and indication: not reported). The batch number reported was 30130BA.  On 07-Oct-2021, one day after receiving Afluria Quadrivalent and non-company, co-suspect Pfizer BioNTech COVID-19 vaccine, the patient experienced heightened sense of smell that had persisted.  On unspecified date, the patient visited physician office, however no further details were provided.  At the time of the initial reporting, the patient had not recovered from the event.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: A 53-year-old male patient experienced heightened sense of smell one day after vaccination with the suspect Afluria Quadrivalent vaccine. Causality was confounded by concurrent vaccination with non-company co-suspect Pfizer-Biontech COVID-19 vaccine. Nevertheless, causality for the event is assessed as possibly related based on plausible temporal relationship. Sender's Comments: A 53-year-old male patient experienced heightened sense of smell one day after vaccination with the suspect Afluria Quadrivalent vaccine. Causality was confounded by concurrent vaccination with non-company co-suspect Pfizer-Biontech COVID-19 vaccine. Nevertheless, causality for the event is assessed as possibly related based on plausible temporal relationship.
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/1/2023 LUNG CANCER, RIGHT UPPER LOBE
Developed half dollar red knot on right upper arm 9/6/06 on 9/7/06 redness worse c/o pain, came back to clinic where pt found to have 4x4 inch hot, firm, erythematous area right upper arm, very tender to touch, able to move arm with ease. Instructed to use ice, Benadryl. 9/8/06 most of redness gone, slight warmth, still firm, no tender.
DEC 2013 START- HEADACHES, DIZZINESS, PERIPHERAL VISION AFFECTED, GRADUAL WORSENING OVER FUTURE MONTHS WITH NUMBNESS IN FINGERS, WEAKENING ARM AND LEG STRENGTH, PROXIMAL MUSCLES AFFECTED, E.G. CAN'T CLIMB STAIRS OR OPEN MILK GALLON OR CARRY BABY DAUGHTER. GRADUALLY WORSENS TO WEAR CAN'T SIT ON TOILET SEAT MYSELF OR GET UP FROM COUCH. TAKEN TO E.R. IN 2014 AND ADMITTED AFTER TESTS. PROVIDED PLASMAPHERESIS TREATMENTS WHICH HELP A LITTLE AND WAS RELEASED. RELAPSE WITHIN A FEW WEEKS WITH SYMPTOMS RAPIDLY RETURNING. VISIT E.R IN SUMMER 2014 AND READMITTED. MORE PLASMAPHERESIS TREATMENTS GIVEN, NERVE AND MUSCLE BIOPSY TAKEN WITH NO NEW DIAGNOSIS. RELEASED ONLY TO RELAPSE AGAIN WITHIN A FEW WEEKS, WITH SYMPTOMS WORSENING EACH TIME. CAN BARELY WALK, NEED SPOUSE TO LIFT AND CARRY ME TO TOILET, COUCH ETC. CAN'T FEED MYSELF OR CARRY/HOLD MY LITTLE BABY DAUGHTER THIS WHOLE TIME. GO THIS TIME TO E.R. AND ADMITTED AGAIN INTO HOSPITAL. DIAGNOSIS MADE OF CIDP AND GIVEN METHYL PREDNISONE. KEPT FOR 5 DAYS AND RELEASED. RELAPSE OVER WEEKEND AND READMITTED INTO SAME E.R AND TO SPECIALTY FACILITY ON MONDAY AM. THIS TIME GIVEN HIGH DOSAGE IVIG TREATMENT AND SLIGHT RECOVERY. RELEASED AND GIVEN HIGH DOSAGE IVIG TREATMENT ALONG WITH ORAL PREDNISONE TREATMENT. I HAVE EVER SINCE TO THIS DAY RECEIVED IVIG TREATEMENT EVERY 4 WEEKS IN A HIGH DOSAGE, AS OTHERWISE I WILL RELAPSE WITH CIDP SYMPTOMS RECURRING.
Intense pain at injection site Nausea  Vomiting Diarrhea  Fever Body aches Chills Stomach ache
Patient was due for pfizer age 5-11 booster. The vaccine was not diluted before being administered.
Headache chills and fatigue, Narrative: missed one day of work, took a bivax test for covid that wasnegative
Dizziness, Myalgia, Arthralgia, Fever &  NauseaVomiting Narrative:
According to patient, approximately 5 hours post immunization experienced chills, fatigue, fever (101.2) and redness, swelling and soreness in the affected arm;unable to raise arm above her head. Saw her personal MD who placed her on antibiotics (Bactrim). By the following day, the arm was less swollen and red and the patient was released by her physician to go on vacation.
presented at the clinic for a booster shot of Moderna after his initial Jannsen vaccine. He received the Moderna Booster vaccine (lot 037F21A) to the LD at 1333 and experienced what appeared to be a vasovagal event while seated in the vaccination chair immediately after his vaccine. MAOlga Torreblanca alerted this writer, RN. Mr. presented with diaphoresis and pallor, was slumped in the chair, and was unresponsive to touch or verbal stimuli for approximately 30-40 seconds.  He recovered spontaneously and reported that he felt a touch dizzy. He also reported that he was very anxious before the vaccine and that he has an extensive history of vasovagal events after vaccination or blood draws. His vital signs at 1340 were: BP sitting 110/60, HR was 72, and SPO2 was 98% on RA. At 1341, he transferred to the cot, rising from the chair without difficulty and walking with a steady gait. He accepted juice and ate a snack that he had brought with him. His pallor had improved and he was no longer diaphoretic at this point.  At 1348, he reported that he felt less dizzy and almost normal. At 1352, he attempted to sit at the edge of the cot, but reported that increased his dizziness and elicited a tingling sensation to his hands. Vital signs at this time were: BP 96/62 sitting, HR 81 and SPO2 99% on RA. He laid back down and continued to work on PO fluid intake. Both he and his wife reported that they were unsure what his baseline BP ,was.  At 1401, he denied dizziness or tingling sensations, but reported that he felt off. His VS at 1401 were: BP 100/60 laying with an HR of 68. By 1416, he was able to sit up and reported that he felt slightly better. Not quite as dizzy. Maybe 85-90% normal.? At 1418, his BP sitting was 102/66, HR was 60, and SPO2 was 99% on RA.  At 1420, he rose and stood without difficulty. His BP was 98/62 standing, HR 67, SPO2 was 99% RA. He walked a few steps without trouble and with a steady gait. At 1429, he was standing and reporting that he felt normal. His BP standing was 102/64, HR was 59, and SPO2 was 98% on RA.  Both Mr. and his wife were educated on vasovagal responses and when to seek medical care. His wife reports that she will drive them home and stay with Mr. to monitor him throughout the day. They exited the facility at 1429.
COVID-19 breakthrough infection one week after 2nd booster.  Previous booster was 11/29/21.   Second infection with COVID-19.  Symptoms of this infection were much more mild-congestion, headache, sore throat mild fever (less than 100)
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Weakness-Mild, Additional Details: 5 minutes following second dose of pfizer pt with syncopal episode. LOC for 10 seconds, came to spontaneously without intervention. Pt placed in trendelenburg, regained consciousness. vital signs stable, blood sugar stable, no injury.
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information about patient's pertinent medical history, concomitant medications and drug reactions or allergies reported. On 14-OCT-2015, the patient was vaccinated with an improperly stored dose of M-M-R II recombinant human albumin (rHA) status (lot# J016232, expiration date, dose, anatomical location and route of administration were not reported). The reason for the temperature excursion was, because the daily vaccine counts caused the storage unit to have temperature fluctuations because of door opening. No adverse events were reported. This is one of the several reports received from the same reporter. Additional information is not expected, as no further information is available.
Had 104.5 Temperature went to hospital they gave TYLENOL to reduce fever, which it did and was fine after.
Sinus Infection; congestion; vertigo; This case was reported by a consumer via call center representative and described the occurrence of sinus infection in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 2 weeks after receiving Shingrix, the patient experienced sinus infection, nasal sinus congestion and vertigo. On an unknown date, the outcome of the sinus infection, nasal sinus congestion and vertigo were unknown.   It was unknown if the reporter considered the sinus infection, nasal sinus congestion and vertigo to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced sinus Infection two weeks after receiving initial Shingrix vaccine. The patient stated that it started with congestion and she also had vertigo. The reporter did not consent to follow-up.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 11-MAY-2011, the patient was inoculated with the ZOSTAVAX vaccine at the health department for routine adult health maintenance and the intended purpose for the prevention of shingles. The vaccine did not prevent shingles as intended. The patient subsequently contracted a persistent strain of herpes zoster, the very virus the ZOSTAVAX vaccine was intended to prevent. In July 2015, the patient was treated by a family physician at the office for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Pt admitted to Hospital with abdominal pain, nausea, and pneumonia. Tested positive for COVID-19. Pt states that they are fully vaccinated for COVID. Unknown manufacturer or dates of vaccination. Unable to obtain additional information.